Danielle Antalffy

Stock Analyst at UBS

(3.42)
# 939
Out of 4,650 analysts
173
Total ratings
48.21%
Success rate
3.69%
Average return

Stocks Rated by Danielle Antalffy

Abbott Laboratories
Oct 17, 2024
Maintains: Buy
Price Target: $143$146
Current: $114.07
Upside: +27.99%
Edwards Lifesciences
Sep 10, 2024
Maintains: Neutral
Price Target: $90$75
Current: $68.52
Upside: +9.46%
Medtronic
Aug 15, 2024
Upgrades: Neutral
Price Target: $76$90
Current: $90.60
Upside: -0.66%
Zimmer Biomet Holdings
Aug 8, 2024
Maintains: Sell
Price Target: $112$107
Current: $103.60
Upside: +3.28%
Treace Medical Concepts
Aug 7, 2024
Maintains: Neutral
Price Target: $6.5$7
Current: $4.84
Upside: +44.63%
Stryker
Jul 31, 2024
Maintains: Neutral
Price Target: $351$366
Current: $356.01
Upside: +2.81%
DexCom
Jul 26, 2024
Maintains: Buy
Price Target: $163$95
Current: $72.10
Upside: +31.76%
Boston Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $74$90
Current: $84.76
Upside: +6.18%
AtriCure
Feb 16, 2024
Maintains: Buy
Price Target: $57$58
Current: $28.75
Upside: +101.74%
InMode
Feb 14, 2024
Maintains: Neutral
Price Target: $24$26
Current: $17.98
Upside: +44.61%
Initiates: Buy
Price Target: $75
Current: $41.17
Upside: +82.17%
Upgrades: Buy
Price Target: $180
Current: $161.60
Upside: +11.39%
Maintains: Buy
Price Target: $405$322
Current: $194.68
Upside: +65.40%
Initiates: Neutral
Price Target: $2.25
Current: $1.89
Upside: +19.05%
Initiates: Neutral
Price Target: $43
Current: $36.01
Upside: +19.41%
Initiates: Neutral
Price Target: $278
Current: $510.88
Upside: -45.58%
Initiates: Neutral
Price Target: $45
Current: $32.75
Upside: +37.40%
Maintains: Outperform
Price Target: $16$14
Current: $50.25
Upside: -72.14%
Maintains: Outperform
Price Target: $300$280
Current: $233.37
Upside: +19.98%
Maintains: Outperform
Price Target: $65$55
Current: $0.55
Upside: +9,831.38%
Maintains: Outperform
Price Target: $12$14
Current: $13.94
Upside: +0.43%
Maintains: Outperform
Price Target: $75$100
Current: $110.10
Upside: -9.17%
Maintains: Outperform
Price Target: $15$12
Current: $6.38
Upside: +88.09%
Maintains: Outperform
Price Target: $25$30
Current: $91.00
Upside: -67.03%
Maintains: Outperform
Price Target: $60$65
Current: $70.24
Upside: -7.46%
Maintains: Outperform
Price Target: $40$45
Current: $45.66
Upside: -1.45%
Maintains: Outperform
Price Target: $105$85
Current: $4.91
Upside: +1,631.16%
Maintains: Outperform
Price Target: $85$95
Current: $42.56
Upside: +123.21%
Maintains: Market Perform
Price Target: $270$275
Current: $238.91
Upside: +15.11%
Maintains: Outperform
Price Target: $26$20
Current: $2.95
Upside: +577.97%
Maintains: Market Perform
Price Target: $72$42
Current: $9.29
Upside: +352.34%
Downgrades: Market Perform
Price Target: $3
Current: $0.34
Upside: +770.07%
Initiates: Outperform
Price Target: $15
Current: $1.01
Upside: +1,385.15%